Atlas Trials

Recombinant Vaccinia Virus Administered Intravenously in Patients With Metastatic, Refractory Colorectal Carcinoma

Clinical trial NCT01394939 · COMPLETED

Trial details

NCT number
NCT01394939
Sponsor
Jennerex Biotherapeutics
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Colorectal CarcinomaCRC
Start date
2012-01-01
Primary completion
2015-06-01
Enrollment
52

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.